These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19417623)

  • 41. B-cell chronic lymphocytic leukemia: correlation of clinical stages with angiogenic cytokine expression.
    Ho CL; Phyliky RL; Li CY
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):154-60. PubMed ID: 16785782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
    Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
    Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
    Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
    Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A clinical update on chronic lymphocytic leukemia. I. Diagnosis and prognosis.
    Tefferi A; Phyliky RL
    Mayo Clin Proc; 1992 Apr; 67(4):349-53. PubMed ID: 1548950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
    Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
    Smolej L; Kasparová P
    APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of diagnostic and prognostic parameters (including flow cytometry) in chronic lymphoproliferative disorders: the Indian perspective.
    Kumar N; Varma N; Varma S; Malhotra P
    Anal Quant Cytol Histol; 2009 Oct; 31(5):296-303. PubMed ID: 20701097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
    Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
    Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
    Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit.
    Pangalis GA; Roussou PA; Kittas C; Kokkinou S; Fessas P
    Cancer; 1987 Feb; 59(4):767-71. PubMed ID: 3492263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expressions of ki-67 and bcl-2 in 29 cases of chronic lymphocytic leukemia and their clinical significance].
    Xu W; Li JY; Wu YJ; Sheng RL; Lu FX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):464-7. PubMed ID: 16800921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
    Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M
    Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.
    Rao DS; O'Connell RM; Chaudhuri AA; Garcia-Flores Y; Geiger TL; Baltimore D
    Immunity; 2010 Jul; 33(1):48-59. PubMed ID: 20598588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.
    Prieto D; Oppezzo P
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29206143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic markers and stratification of chronic lymphocytic leukemia.
    Furman RR
    Hematology Am Soc Hematol Educ Program; 2010; 2010():77-81. PubMed ID: 21239774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic alterations in a murine model for chronic lymphocytic leukemia.
    Chen SS; Sherman MH; Hertlein E; Johnson AJ; Teitell MA; Byrd JC; Plass C
    Cell Cycle; 2009 Nov; 8(22):3663-7. PubMed ID: 19901553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Marrow histomorphology and clinical staging of chronic lymphocytic leukemia--a rare disease in India: experience with 26 cases.
    Singh T; Basu D; Prakash S; Rani S; Gaiha M
    Leuk Lymphoma; 1993 May; 10(1-2):117-9. PubMed ID: 8374519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
    Visone R; Veronese A; Balatti V; Croce CM
    Oncotarget; 2012 Feb; 3(2):195-202. PubMed ID: 22350310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.